Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins
about
Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patientsCXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infectionFunctional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis.Touch of chemokines.Sex-specific regulation of chemokine Cxcl5/6 controls neutrophil recruitment and tissue injury in acute inflammatory states.Suppression of endothelial P-selectin expression contributes to reduced cell trafficking in females: an effect independent of NO and prostacyclin.CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults.Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.).Low level of inflammatory marker in hyperhomocysteinemic patients on statin therapy.ATP Evokes Ca2+ Responses and CXCL5 Secretion via P2X4 Receptor Activation in Human Monocyte-Derived Macrophages.Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease.Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes.Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis.Deregulated microRNA and mRNA expression profiles in the peripheral blood of patients with Marfan syndrome.
P2860
Q28397434-876760CF-00C6-4D63-8B66-88D1067A472CQ28589805-C0730907-AB36-4B8D-8021-936BADF698EBQ35889058-5B406650-82C4-4249-BD65-BB12B31276EEQ36090029-B3CBBC75-B993-44FF-9CEA-AE35602BF27AQ36324954-AEA708B7-D6F7-4754-AECC-F7DEB5786178Q36410132-87FF9AC5-D75A-49D8-9C5C-9CF83CC9050FQ36420743-B7EED9CB-DC52-4EBC-B2CA-3CEEEAC97B1FQ42324464-D8EEFA89-8C7F-48B2-86D3-BEA7A9DEB45FQ44914830-E95FEB98-C2E2-465F-AD82-FECD7DB0DA03Q47286564-D9D68AF5-DD67-465C-84D5-8D45F568BD2FQ47385143-D3648DF8-9B76-4B39-BB4E-75E6D68E2C9DQ47387223-C0B4ABDA-F27D-4F0C-BD79-DB8E9FB889F2Q51372933-124C29C5-81E0-4BF6-9491-31488CBE4E63Q53773141-0930155D-678E-40DE-907C-00D04087FEA8Q54940461-679BF94F-5376-4E5D-978E-1DEC3AE43BF0
P2860
Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Epithelial neutrophil-activati ...... d modulatory effect of statins
@ast
Epithelial neutrophil-activati ...... d modulatory effect of statins
@en
Epithelial neutrophil-activati ...... d modulatory effect of statins
@nl
type
label
Epithelial neutrophil-activati ...... d modulatory effect of statins
@ast
Epithelial neutrophil-activati ...... d modulatory effect of statins
@en
Epithelial neutrophil-activati ...... d modulatory effect of statins
@nl
prefLabel
Epithelial neutrophil-activati ...... d modulatory effect of statins
@ast
Epithelial neutrophil-activati ...... d modulatory effect of statins
@en
Epithelial neutrophil-activati ...... d modulatory effect of statins
@nl
P2093
P2860
P1433
P1476
Epithelial neutrophil-activati ...... d modulatory effect of statins
@en
P2093
Amber L Beitelshees
Gregory J Welder
Issam Zineh
Michael A Province
Nasser Chegini
Sharon Cresci
P2860
P356
10.1371/JOURNAL.PONE.0003117
P407
P577
2008-09-03T00:00:00Z